Completed NA INTERVENTIONAL 2-arm NCT00705900

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

A Randomized, Single-Blind, Active Control, 18-Week Study to Evaluate the Safety and Efficacy of A New Twice-Daily, Topically Applied LCD Solution vs. Calcipotriol Cream for the Treatment of Adult Subjects With Moderate Plaque Psoriasis

Sponsor: NeoStrata Company, Inc.

Conditions Chronic Plaque Psoriasis

Interventions LCD calcipotriol

Updated 5 times since 2017 Last updated: Nov 17, 2008 Started: Jan 31, 2007 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Chronic Plaque Psoriasis and is currently completed. NeoStrata Company, Inc. leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeoStrata Company, Inc.

Data source: NeoStrata Company, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States